From CRISIL
Ipca Laboratories has received revision in ratings for the bank facilities aggregating Rs 1182.5 crore of the Company from CRISIL.Long term rating - CRISIL AA-/ Stable (Downgraded from CRISIL AA/ Negative)
Rs 15 crore NCDs - CRISIL AA-/ Stable (Downgraded from CRISIL AA/ Negative)
Rs 50 crore Short term debt - CRISIL A1+ (Reaffirmed)
Powered by Capital Market - Live News
